Pyxis Oncology, Inc. (PYXS) Net margin 2024–2025
Pyxis Oncology, Inc. (PYXS) net profit margin by fiscal year — reported net income divided by reported revenue.
-574.5%FY2025 · since FY2024: -478.9% → -574.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -574.5% | -95.6 pp |
| FY2024 | -478.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →